EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, RGNX: Regenxbio Inc

17 Jul 26 15:59
LAST:

9.870

CHANGE:
 1.31		OPEN:
9.280		HIGH:
10.240		ASK:
29.250		VOLUME:
6.16M
CHG(%):
11.70		PREV:
11.200		LOW:
8.420		BID:
15.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
17 Jul 268.99010.2408.4209.8907.52M
16 Jul 2612.15012.15011.01511.2002.01M
15 Jul 2612.16012.36011.83012.2701.2M
14 Jul 2613.00013.00012.17512.2901.57M
13 Jul 2613.56013.56012.19012.7502.18M
10 Jul 2615.57015.65013.42013.9503.35M
09 Jul 2615.37015.75014.92015.6501.98M
08 Jul 2614.99015.88014.87015.2302.39M
07 Jul 2614.94015.71014.10015.0202.76M
06 Jul 2613.54015.30013.53014.8303.15M

PROFILE

Name:Regenxbio Inc
About:REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase III clinical trial for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I, RGX-181 for the treatment of late-infantile neuronal ceroid lipofuscinosis type 2, and RGX-381 for the treatment of the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
Sector:Healthcare
Industry:Biotechnology
Address:9804 Medical Center Drive, Rockville, MD, United States, 20850
Website:https://www.regenxbio.com
CUSIP:75901B107
CIK:0001590877
ISIN:US75901B1070
FIGI:BBG007Z9V591
LEI:549300EOES47LATSET33

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-2.61 
Forward P/E:-5.64 
PEG Ratio:-0.08 
Price to Sales:4.14 
Price to Book:35.59 
Profit Margin:-1.13 
Operating Margin:-2.96 
Return on Assets:-0.18 
Return on Equity:-0.62 
EPS Ratio:-5.60 
Revenue:155.78M 
Shares:51.7M 
Market Cap:510.26M 

TECHNICAL INDICATORS

MA5:11.6818.3%
MA10:13.3134.8%
MA20:12.0422.0%
MA50:9.177.7%
MA100:8.999.8%
MA200:10.617.5%
RSI14:47.30
WPR14:-100.00 
MTM14:-1.94
ROC14:-0.16 
ATR:1.42 
Week High:15.6558.6%
Week Low:8.4217.2%
Month High:15.8860.9%
Month Low:7.187.5%
Year High:16.1964.0%
Year Low:5.4680.9%